Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
- FDA Approves First Extended-Release, Injectable Drug Regimen ... - HIV.gov
[Yesterday] the U.S. Food and Drug Administration approved...
- FDA Approves First Extended-Release, Injectable Drug Regimen ... - HIV.gov
31 Ιουλ 2024 · The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV and AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA).
27 Ιαν 2021 · This is the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month.
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77...
21 Ιαν 2021 · The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type...
22 Ιαν 2021 · [Yesterday] the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral ...
11 Δεκ 2023 · The coformulated tablet of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) taken orally once daily made history in 2012 as the first US Food and Drug Administration (FDA)-approved treatment for HIV PrEP for HIV uninfected adults (> 17 years of age).
